GREENWICH LIFESCIENCES, INC.

GLSI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2022 Mar 2022 Dec 2021 Sep 2021 Jun 2021 Mar 2021
Operating Activities
Net Income $-746.1K $-2.0M $-2.4M $-863.1K $-749.7K $-597.0K
Depreciation & Amortization
Depreciation
Amortization
Stock-Based Compensation $224.5K $165.3K $165.4K $165.1K $165.1K $165.1K
Net Cash from Operating Activities $-532.7K $-1.9M $-2.3M $-894.6K $-604.3K $-528.3K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities
Financing Activities
Dividends Paid
Stock Repurchases $2.0M $5.5M
Net Cash from Financing Activities $-2.0M $-5.5M $562.6K $0 $0 $2.3M
Net Change in Cash $-2.6M $-7.5M $-1.7M $-894.6K $-604.3K $1.7M
Free Cash Flow
← Newer Page 3 of 3 Older →